What to review before a Vivitrol visit

Before a Vivitrol visit

Vivitrol preparation includes alcohol status, every recent opioid exposure, medical history and a pain-treatment plan. These checks apply even when the injection is requested for alcohol use disorder.

Describe recent opioids completely

Include prescription pain medicines, tramadol, cough or other opioid-containing products, heroin, fentanyl, methadone and buprenorphine. Tell the clinician about a recent injection or detox stay. Do not leave out a medicine because it was taken for pain rather than to get high.

Assess the opioid-free starting point

The clinician considers the type of opioid, dependence, symptoms and appropriate testing or challenge. A fixed countdown or negative screen cannot guarantee safety. Transitions from methadone or buprenorphine can remain vulnerable to severe precipitated withdrawal longer than short-acting exposure.

Plan alcohol and pain care

For the alcohol indication, you should be able to abstain before initiation and must not be actively drinking at the first administration. Dangerous withdrawal needs separate care. Discuss surgery, dental procedures and how emergency teams will know that opioid blockade is present.

Vivitrol extended-release naltrexone

Vivitrol is a monthly injection of naltrexone. It is used for alcohol dependence in patients able to abstain before starting, and to prevent relapse to opioid dependence after detoxification. Those are different starting situations. The evaluation needs to establish which condition is being treated, whether withdrawal has been safely addressed and whether a month-long opioid blocker fits your health and pain-treatment needs.

Eligibility: Vivitrol extended-release naltrexone

For alcohol dependence, the first injection is for a patient who can abstain in an outpatient setting and is not actively drinking at administration. Every patient needs an opioid exposure review, even when alcohol is the reason for treatment. Pain medicines, tramadol, methadone, buprenorphine and opioid-containing cough or diarrhea remedies matter. Current opioid dependence, acute opioid withdrawal, a positive opioid urine screen or a failed naloxone challenge are label contraindications. Liver history and pregnancy require individual review.

What to expect: Vivitrol extended-release naltrexone

Check withdrawal and readiness

The clinician asks about the last drink, alcohol withdrawal history and recent opioids. Prior seizures, confusion or severe withdrawal may require medical withdrawal care before a relapse-prevention discussion. For opioid treatment, simply counting days since last use cannot prove that the injection is safe.

Review medicines and pain needs

Bring all prescriptions, nonprescription medicines and supplements. Discuss surgery, dental work, chronic pain and emergency pain plans. Naltrexone can block opioid analgesia. A negative urine result or a tolerated test does not guarantee that precipitated withdrawal is impossible, so the whole history matters.

Arrange the injection after clearance

A healthcare provider prepares Vivitrol and gives a deep intramuscular injection into the buttock. It is not a self-injection and is not interchangeable with an oral tablet. Oral naltrexone pretreatment is not required by the label, although the clinician may discuss prior experience or another supervised step.

Build continuing support

Discuss triggers, sleep, mood, counseling and what to do if drinking or opioid use returns. Set the next injection date and identify who handles a gap in medication delivery. Recovery needs can change even when injections are on schedule, so follow-up should assess life outside the appointment too.

Preparing for your appointment

Bring the last opioid and alcohol use dates, medication containers, detox/discharge records, previous naltrexone experience and liver test results if available. Be honest about any opioid exposure after the appointment was booked. Tell the clinician about prior injection reactions, bleeding concerns and pregnancy. Ask whether the appointment is an evaluation or a confirmed administration visit and how to contact the team if plans change.

Risks and when to seek help

Starting too soon after opioids can cause sudden, severe withdrawal that may need hospital care. The label generally recommends at least seven to ten opioid-free days after short-acting opioids; vulnerability after buprenorphine or methadone may last longer. Your clinician determines readiness. Never try to overcome the blockade with larger opioid amounts. Overdose risk rises as the injection wears off, after a missed dose or after stopping because opioid tolerance may be lower. Seek prompt assessment for worsening injection-site swelling, open wounds, jaundice, dark urine or severe abdominal pain. Call 911 for an overdose or another medical emergency.

Follow-up and treatment review

Vivitrol is usually given every four weeks or once a month. Contact the prescriber promptly if an injection is missed, especially if opioids were used during the gap. Re-starting still requires an opioid-free assessment. Report persistent cravings, alcohol use, depression and side effects; they are reasons to revisit the plan. Agree on access to naloxone or another suitable overdose-reversal medicine when opioid exposure is possible.

Appointments, costs and coverage

Ask what the estimate includes: evaluation, medicine, administration, tests and follow-up may be separate. Coverage authorization and medication arrival should be confirmed before the injection appointment is final. If treatment was started in another program, send the last injection date and records so care can continue safely. Confirm the administering site rather than assuming every evaluation location can give the injection.

Medical sources

• VIVITROL: prescribing information
• MedlinePlus: naltrexone injection
• CDC: five things to know about naloxone
• NIAAA: treatment for alcohol problems
• SAMHSA: treatment options for substance use disorder
• DailyMed: naltrexone hydrochloride tablets